TAKE Solutions Ltd. Enabling Business Efficiencies Corporate - PowerPoint PPT Presentation

TAKE Solutions Ltd. Enabling Business Efficiencies Corporate Presentation TAKE : T echnology, A nalytics & K nowledge for the E nterprise

Contents  TAKE – At A Glance  Business Model & Market Potential  Competencies − Life Sciences − Supply Chain Management  Financials  Growth Strategies & Key TAKEaways  Appendix 2

TAKE Solutions – At A Glance About TAKE Marquee Clients  We serve 410+ clients through 14 offices globally  Headquartered in Chennai, India, TAKE Solutions Ltd. with 1,100+ employees delivers technology, services and expert advice in Life Sciences and Supply Chain Management domains  Life Sciences: Celgene, Eisai, Johnson & Johnson, Merck, Neuromed, Novartis, Pfizer, Roche, Sanofi  Strong presence in US, Europe and Middle East Asia: US Aventis contributes approx. 2/3 of revenue  SCM: Applied Materials, Alcoa, GE Group,  CMMi Level 5 accredited company Honeywell, Panasonic, ITC, Pepsi, Transocean, Xerox  Recognitions:  TAKE Solutions receives SDCE 100 Award for Third Financials Consecutive Year  FY14 Revenue : INR 8,217 million  TAKE is ranked Leader in the life science R&D IT  FY14 Net Profit: INR 580 million outsourcing and Drug Safety market by IDC, a premier global provider of market intelligence and advisory 10,000 services IT markets  Ranked first by a premier global analyst firm, for 7,500 INR million industry expertise and overall customer satisfaction in 5,000 Life Sciences domain 2,500  “Editors’ Pick” Distinction by Consumer Goods Technology Magazine 0 FY10 FY11 FY12 FY13 FY14 Revenue Net Profit 3

Global Footprint Strong Presence in the US, Middle East Asia and Europe Hampshire, UK Abraq Khaitan, Kuwait Princeton , NJ Dubai, UAE Philadelphia , PA Muscat , Oman Chennai , India Austin , TX Riyadh, Jeddah & Singapore Al-Khobar Saudi Arabia Global HQ USA HQ Global Delivery Center TAKE Solutions Ltd. TAKE Solutions Inc. TAKE Solutions LLP No.8B, Adyar Club Gate Road, 502 Carnegie Center, Shriram "The Gateway SEZ", Chennai - 600028, India Perungalathur, Chennai, India Suite 100, Princeton, NJ 4

Recognitions and Partnerships Certifications & Accreditation Alliances and Partnerships 2014: Ranked 2 nd at Asia‘s Best Employer Brand Awards,   Oracle Gold Partner Singapore. CMMi Level 5   SAP Business Objects Gold Partner  2013: SDCE 100 Award for Third Consecutive Year 2013: 7 th Employer Branding Award for Excellence in  Training  Microsoft BIO IT alliance Partner  2013: IDC ranked TAKE as Leader in the life science Drug Safety Services market based on our ddemonstrated delivery experience, deep understanding of drug safety processes & platforms and deep strategic drug safety  CDISC Solutions Partner expertise 2011: IDC, a global market intelligence firm, ranked TAKE as  Leader in the life science R&D IT outsourcing market based  Microsoft’s Digital Pharma Initiative on the company’s capabilities and future strategies aligned with what customers will require in three to five years  2011 Supply & Demand Chain Executive 100 list  Microsoft High Impact Gold partner  2010: A premier global analyst firm recognized and ranked TAKE, first among large system integrators for industry expertise & overall customer satisfaction in the Life  Sparta Systems Sciences Domain 2010 “Editors’ Pick” Distinction by Consumer Goods  Technology Magazine  Generis Global Logistics & Supply Chain Strategies 2010: 100 Great  Supply Chain Partners List 5

Business Model & Market Potential

TAKE Solutions – Business Model TRANSACTIONS /  SUBSCRIPTIONS  Maintenance REVENUE  model   Services  Licenses DELIVERY On Business SaaS Premise model Services Virtualization Cloud Computing TECHNOLOGY Embedded / RFID / Mobile Service Oriented Architecture (SOA) DOMAIN Supply Chain Management & Life Sciences 7

TAKE Solutions – Business Model  Balanced: Well distributed across two key verticals - niche offerings addressing multiple end user industries  Wide Portfolio of Offerings: Solutions to address customer needs - Solutions delivered as business services, products and SaaS  Diversified Customer Base: Portfolio of solutions to address customer size - focused approach to large & mid-market customer segment and wider approach to SME segment  Scalable: Platform agnostic solutions to enhance addressable markets and strategic partnerships to drive penetration in areas of specialization  Diversified Revenue Streams: Income from subscription, licensing, royalties, services and AMC leading to a mix of annuity and non annuity revenues 8

Total Addressable Market Life Sciences Supply Chain Management 12.0 45.0 10.2 40.0 40.0 10.0 35.0 8.0 30.0 25.0 USD billion USD billion 5.7 6.0 20.0 4.0 15.0 10.0 8.0 2.0 5.0 1.0 0.0 0.0 SaaS On Premise Business Services Pre - Approval Post- Approval 9

Domain Competency Life Sciences

Integrated Solutions & Services 11

Software products - Life Sciences Clinical Regulatory Safety Bio Statistical Regulatory Clinical Development Safety Programming Submissions CDISC Accelerators DMS eCTD SPL/PLR TRMS SAS - Bio Statistics PPM Framework eTMF Oracle Life Sciences CTMS, EDC, CDMS, LSH/CDR Argus Safety AERS 12

Established customer relationships; scalable revenue model Increasing customer base Customer A Customer B Customer C Customer D Multiplying revenues Therapeutic Therapeutic Therapeutic Therapeutic Therapeutic Therapeutic Area 1 Area 2 Area 1 Area 2 Area 1 Area 1 Indication A Indication B Indication C Indication D Indication E Phase1 Phase2 Phase1 Phase2 Study I Study 1 Study 1 Study 1 Study 1 Study 1 Study 1 Study 1 TLFs, Biostatistics, SDTM, ADaM, ISS/ISE, DMCs, SAP, EAC, NDAs Technology + business services 13

TAKE Life Sciences - Differentiators  Unique combination of deep domain expertise and technical skills  Market penetration across  Bio-pharmaceutical (branded & generic)  Medical device  CROs  Mature infrastructure across USA and APAC  People  Process  Infrastructure – SAS 70* compliant, validated data center  Strategic partnerships with Oracle and Liquent  TAKE’s differentiated approach to markets  Large and mid-market segment : Functional Service Provider  Small and medium segment : Full Service Provider * SAS 70 (the Statement on Auditing Standards No. 70) defines the standards an auditor must employ in order to assess the contracted internal controls of a service organization. Service organizations, such as hosted data centers, insurance claims processors and credit processing companies, provide outsourcing services that affect the operation of the contracting enterprise. 14

TAKE Life Sciences - Strategy 1  Broaden and deepen TAKE LS’ engagements with existing and potential clients by retaining and promoting existing and new portf olio of solutions in clinical, regulatory, safety and content management to obtain new and/or larger contracts from its clients. Enlarge C lients’ Portfolio  In this direction, TAKE LS is also striving to become an important member of FIPNET community which enables it to work effectively together with all its clients, pharmaceutical clients, suppliers, partners and regulators. 2  Commit its resources to focus on US and European clients, ensuring it is at the forefront of regulatory and market developments on multiple Focus on US and platforms. European clients  Communicate and showcase its abilities to these clients in order to win projects related to LS process outsourcing and consulting. 3  Leverage on its partners to educate pharmaceutical companies on TAKE LS’ capabilities, for example, in relation to the partners’ platform (e.g. Leverage on Partnerships Oracle) to increase the usage of TAKE LS’ consulting and outsourcing offerings and expand its clientele base. 4  Focus on increasing its offerings which can be monetised across delivery platforms e.g. products, services offered over SaaS platforms. These Focus on the offerings may be developed inhouse or acquired through mergers and acquisitions. Balance d Offering Mix  Enable all offerings to be device agnostic, platform and browser agnostic, to achieve scalability. 15

TAKE assessed as a LEADER in Life Sciences • Capabilities: Evaluated on current capabilities and how well aligned it is to customer needs • Strategies : Indicates how well the company’s future strategy aligns with what customers will require in three to five years Worldwide Life Science R&D IT Outsourcing 2011 Vendor Worldwide Life Science Drug Safety Services 2013 Vendor Assessment Assessment Source: 1. IDC MarketScape: Worldwide Life Science R&D IT Outsourcing 2011 Vendor Assessment, August 2011 2. IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment 16